RELIEF THERAPEUTICS N/ CH1251125998 /
| 2024-11-12 5:31:37 PM | Chg. -0.180 | Volume | Bid9:57:01 PM | Ask9:57:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.440CHF | -2.72% | 441,245 Turnover: 3.11 mill. |
-Bid Size: 700 | -Ask Size: 62 | 90.42 mill.CHF | - | - |
Assets
| 2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2.4000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Intangible Assets | 23.4000 | 20.8000 | 30.8000 | 30.8000 | 35.2000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 25.9000 | 20.8000 | 30.8000 | 30.8000 | 35.2000 | ||||||
| Inventories | .5000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | 3.1000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Cash and Cash Equivalents | 4.2000 | .3000 | .4000 | .1000 | .4000 | ||||||
| Current Assets | 8.7000 | 7.1000 | .6000 | .2000 | .4000 | ||||||
| Total Assets | 34.6000 | 27.9000 | 31.4000 | 31 | 35.6000 | ||||||
Liabilities
| 2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.9000 | .4000 | .4000 | .5000 | .1000 | ||||||
| Long-term debt | 1.4000 | 1.9000 | - | - | - | ||||||
| Liabilities to Banks | 4.5000 | 4.2000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | 1.2000 | .7000 | 6.5000 | 7.5000 | 7.5000 | ||||||
| Liabilities | 12.7000 | 11.5000 | 9.2000 | 10 | 14.3000 | ||||||
| Share Capital | 5.4000 | 5.4000 | 19.5000 | 20.1000 | 20.9000 | ||||||
| Total Equity | 21.9000 | 16.3000 | 22.2000 | 20.9000 | 21.3000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 34.6000 | 27.9000 | 31.4000 | 31 | 35.6000 | ||||||
Income Statement
| 2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 16.2000 | .2000 | 0.0000 | 0.0000 | .6000 | ||||||
| Depreciation (total) | 5.2000 | .3000 | 14.5000 | - | - | ||||||
| Operating Result | -10.1000 | -3.5000 | -16.5000 | -1.7000 | -.5000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -10.4000 | -4 | -16.8000 | -1.9000 | -.4000 | ||||||
| Income Taxes | .2000 | 0.0000 | 0.0000 | -1 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -10.2000 | -8.5000 | -16.8000 | -2.9000 | -.4000 | ||||||
Per Share
Cash Flow
| 2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -7.3000 | -6.2000 | -2.9000 | -1.2000 | -.6000 | ||||||
| Cash Flow from Investing Activities | -.5000 | 1 | .1000 | 0.0000 | 0.0000 | ||||||
| Cash Flow from Financing | 11.2000 | 2.1000 | 3.1000 | .9000 | .7000 | ||||||
| Decrease / Increase in Cash | 3.4000 | -3 | .4000 | -.3000 | .1000 | ||||||
| Employees | - | - | - | - | - | ||||||
